Skip to main content
Top
Published in: Clinical Rheumatology 5/2014

01-05-2014 | Original Article

Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)

Authors: Luiza F. Rocha, Roberta G. Marangoni, Percival D. Sampaio-Barros, Mauricio Levy-Neto, Natalino H. Yoshinari, Eloisa Bonfa, Virginia Steen, Sergio C. Kowalski

Published in: Clinical Rheumatology | Issue 5/2014

Login to get access

Abstract

The Scleroderma Health Assessment Questionnaire (SHAQ) is a feasible multisystem specific tool that has been extensively used as an additional assessment for systemic sclerosis (SSc). The aim of this study is to cross-culturally adapt and validate the Brazilian version of the SHAQ. Construct validity was assessed based on the correlations between SHAQ and both the Medical Outcomes Survey Short Form 36 version 2 (SF-36v2™) and the Health Assessment Questionnaire Disability Index (HAQ-DI). The correlation between the SHAQ and disease severity was assessed by Spearman's correlation coefficient. The reproducibility of the SHAQ was evaluated by the intraclass correlation coefficient (ICC). Among the 151 consecutive outpatients evaluated, 59 % had limited SSc subtype. The overall disease severity visual analog scale (VAS) of the SHAQ was statistically significantly correlated to HAQ-DI, pain VAS, and the SF-36v2™ physical component summary score (r = 0.595, r = 0.612, and r = −0.582, respectively; p < 0.001). Further analysis of all SF-36v2™ components revealed statistically significant correlations between overall disease severity VAS and bodily pain (r = −0.621, p < 0.001), vitality (r = −0.544, p < 0.001), physical function (r = −0.510, p < 0.001), and role limitation-physical dimensions (r = −0.505, p < 0.001). Moreover, digestive, pulmonary, and overall disease severity VASs were statistically significantly correlated to the number of organs involved (r = 0.178, p = 0.029; r = 0.214, p = 0.008; r = 0.282, p < 0.001). We also demonstrated high reproducibility for SHAQ (ICC = 0.757, 95 % confidence interval = 0.636–0.842). The Brazilian version of the SHAQ demonstrated both construct and discriminant validities as well as good reproducibility.
Appendix
Available only for authorised users
Literature
1.
go back to reference Charles C, Clements P, Furst DE (2006) Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 367:1683–1691PubMedCrossRef Charles C, Clements P, Furst DE (2006) Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 367:1683–1691PubMedCrossRef
2.
go back to reference Ramos-Casals M, Fonollosa-Pla V, Brito-Zerón P, Sisó-Almirall A (2010) Targeted therapy for systemic sclerosis: how close are we? Nat Rev Rheumatol 6:269–278PubMedCrossRef Ramos-Casals M, Fonollosa-Pla V, Brito-Zerón P, Sisó-Almirall A (2010) Targeted therapy for systemic sclerosis: how close are we? Nat Rev Rheumatol 6:269–278PubMedCrossRef
4.
go back to reference Poole JL, Steen VD (1991) The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4:27–31PubMedCrossRef Poole JL, Steen VD (1991) The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4:27–31PubMedCrossRef
5.
go back to reference Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145PubMedCrossRef Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145PubMedCrossRef
6.
go back to reference Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9:789–793PubMed Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9:789–793PubMed
7.
go back to reference Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40:1984–1991PubMedCrossRef Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40:1984–1991PubMedCrossRef
8.
go back to reference Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M et al (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44:653–661PubMedCrossRef Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M et al (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44:653–661PubMedCrossRef
9.
go back to reference Danieli E, Airò P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I et al (2005) Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24:48–54PubMedCrossRef Danieli E, Airò P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I et al (2005) Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24:48–54PubMedCrossRef
10.
go back to reference Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O et al (2005) Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24:3–10PubMedCrossRef Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O et al (2005) Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24:3–10PubMedCrossRef
11.
go back to reference La Montagna G, Cuomo G, Chiarolanza I, Ruocco L, Valentini G (2006) HAQ-DI Italian version in systemic sclerosis. Reumatismo 58:112–115, In ItalianPubMed La Montagna G, Cuomo G, Chiarolanza I, Ruocco L, Valentini G (2006) HAQ-DI Italian version in systemic sclerosis. Reumatismo 58:112–115, In ItalianPubMed
12.
go back to reference Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y et al (2003) Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. J Rheumatol 30:1253–1258PubMed Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y et al (2003) Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. J Rheumatol 30:1253–1258PubMed
13.
go back to reference Ruof J, Brühlmann P, Michel BA, Stucki G (1999) Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). Rheumatology (Oxford) 38:535–542CrossRef Ruof J, Brühlmann P, Michel BA, Stucki G (1999) Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). Rheumatology (Oxford) 38:535–542CrossRef
14.
go back to reference Silman A, Akesson A, Newman J, Henriksson H, Sandquist G, Nihill M et al (1998) Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25:79–83PubMed Silman A, Akesson A, Newman J, Henriksson H, Sandquist G, Nihill M et al (1998) Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25:79–83PubMed
15.
go back to reference Ostojić P, Damjanov N (2006) The scleroderma assessment questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis. Z Rheumatol 65:168–175PubMedCrossRef Ostojić P, Damjanov N (2006) The scleroderma assessment questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis. Z Rheumatol 65:168–175PubMedCrossRef
16.
go back to reference Smyth AE, MacGregor AJ, Mukerjee D, Brough GM, Black CM, Denton CP (2003) A cross-sectional comparison of three self-reported functional indices in scleroderma. Rheumatology (Oxford) 42:732–738CrossRef Smyth AE, MacGregor AJ, Mukerjee D, Brough GM, Black CM, Denton CP (2003) A cross-sectional comparison of three self-reported functional indices in scleroderma. Rheumatology (Oxford) 42:732–738CrossRef
17.
go back to reference Pope J (2011) Measures of systemic sclerosis (scleroderma). Arthritis Care Res (Hoboken) 63:S98–S111CrossRef Pope J (2011) Measures of systemic sclerosis (scleroderma). Arthritis Care Res (Hoboken) 63:S98–S111CrossRef
18.
go back to reference Johnson SR, Hawker GA, Davis AM (2005) The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 53:256–262PubMedCrossRef Johnson SR, Hawker GA, Davis AM (2005) The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 53:256–262PubMedCrossRef
19.
go back to reference Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M, Canadian Scleroderma Research Group (2009) Clinical correlates of self-reported physical health status in systemic sclerosis. J Rheumatol 36:1226–1229PubMedCrossRef Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M, Canadian Scleroderma Research Group (2009) Clinical correlates of self-reported physical health status in systemic sclerosis. J Rheumatol 36:1226–1229PubMedCrossRef
20.
go back to reference Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, Scleroderma Lung Study Group et al (2007) Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum 56:1676–1684PubMedCrossRef Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, Scleroderma Lung Study Group et al (2007) Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum 56:1676–1684PubMedCrossRef
21.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
22.
go back to reference Clements PJ (1995) Measuring disease activity and severity in scleroderma. Curr Opin Rheumatol 7:517–521PubMedCrossRef Clements PJ (1995) Measuring disease activity and severity in scleroderma. Curr Opin Rheumatol 7:517–521PubMedCrossRef
23.
go back to reference Chacko KA (1995) AHA medical/scientific Statement: 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation 92:2003–2005PubMed Chacko KA (1995) AHA medical/scientific Statement: 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation 92:2003–2005PubMed
24.
go back to reference Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P (1990) Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 17:813–817PubMed Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P (1990) Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 17:813–817PubMed
25.
go back to reference Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1999) Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol 39:143–150 Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1999) Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol 39:143–150
26.
go back to reference Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33:AS264–AS279PubMedCrossRef Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33:AS264–AS279PubMedCrossRef
27.
go back to reference Ware JE, Kosinki M, Gandek B (2000) SF-36 health survey: manual & interpretation guide. QualityMetric, Inc., Lincoln Ware JE, Kosinki M, Gandek B (2000) SF-36 health survey: manual & interpretation guide. QualityMetric, Inc., Lincoln
28.
go back to reference Laguardia J, Campos MR, Travassos CM, Najar AL, Anjos LA, Vasconcellos MM (2011) Psychometric evaluation of the SF-36 (v.2) questionnaire in a probability sample of Brazilian households: results of the survey Pesquisa Dimensões Sociais das Desigualdades (PDSD), Brazil. Health Qual Life Outcomes 9:61PubMedCentralPubMedCrossRef Laguardia J, Campos MR, Travassos CM, Najar AL, Anjos LA, Vasconcellos MM (2011) Psychometric evaluation of the SF-36 (v.2) questionnaire in a probability sample of Brazilian households: results of the survey Pesquisa Dimensões Sociais das Desigualdades (PDSD), Brazil. Health Qual Life Outcomes 9:61PubMedCentralPubMedCrossRef
29.
go back to reference Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, ISPOR Task Force for Translation and Cultural Adaptation et al (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94–104PubMedCrossRef Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, ISPOR Task Force for Translation and Cultural Adaptation et al (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94–104PubMedCrossRef
30.
go back to reference Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42PubMedCrossRef Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42PubMedCrossRef
31.
go back to reference Khanna D, Hays RD, Park GS, Braun-Moscovici Y, Mayes MD, McNearney TA et al (2007) Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum 57:1280–1286PubMedCrossRef Khanna D, Hays RD, Park GS, Braun-Moscovici Y, Mayes MD, McNearney TA et al (2007) Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum 57:1280–1286PubMedCrossRef
32.
go back to reference Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61:1112–1120PubMedCrossRef Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61:1112–1120PubMedCrossRef
33.
go back to reference Cohen J (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd edn. Erlbaum L Associates, Mahwah, p 703 Cohen J (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd edn. Erlbaum L Associates, Mahwah, p 703
34.
go back to reference Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Relaxin Study Group, Scleroderma Clinical Trials Consortium et al (2005) Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 32:832–840PubMed Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Relaxin Study Group, Scleroderma Clinical Trials Consortium et al (2005) Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 32:832–840PubMed
35.
go back to reference Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J et al (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 57:94–102PubMedCrossRef Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J et al (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 57:94–102PubMedCrossRef
Metadata
Title
Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)
Authors
Luiza F. Rocha
Roberta G. Marangoni
Percival D. Sampaio-Barros
Mauricio Levy-Neto
Natalino H. Yoshinari
Eloisa Bonfa
Virginia Steen
Sergio C. Kowalski
Publication date
01-05-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2370-8

Other articles of this Issue 5/2014

Clinical Rheumatology 5/2014 Go to the issue